EyeGene Inc.

KOSDAQ:A185490 주식 보고서

시가총액: ₩83.8b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

EyeGene 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Won-Il Yoo

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기24.3yrs
CEO 소유권4.8%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

업데이트 없음

Recent updates

Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Jul 26
Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

Mar 29
Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Feb 01
EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

Dec 07
Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

CEO

Won-Il Yoo

24.3yrs

테뉴어

Mr. Won-Il Yoo has been Chief Executive Officer of EyeGene, Inc. since June 2000. Mr. Yoo has directed EyeGene's initial financing, set-up, recruiting, R&D and business development. He has over 12 years re...